First Time Loading...

Interpace Biosciences Inc
OTC:IDXG

Watchlist Manager
Interpace Biosciences Inc Logo
Interpace Biosciences Inc
OTC:IDXG
Watchlist
Price: 1.55 USD 4.73% Market Closed
Updated: May 29, 2024

Interpace Biosciences Inc
Accrued Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Interpace Biosciences Inc
Accrued Liabilities Peer Comparison

Comparables:
DVA
DGX
CVS
CI
LH

Competitive Accrued Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Accrued Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Interpace Biosciences Inc
OTC:IDXG
Accrued Liabilities
$8.9m
CAGR 3-Years
-4%
CAGR 5-Years
7%
CAGR 10-Years
-7%
DaVita Inc
NYSE:DVA
Accrued Liabilities
$1B
CAGR 3-Years
4%
CAGR 5-Years
3%
CAGR 10-Years
5%
Quest Diagnostics Inc
NYSE:DGX
Accrued Liabilities
$153m
CAGR 3-Years
2%
CAGR 5-Years
1%
CAGR 10-Years
N/A
CVS Health Corp
NYSE:CVS
Accrued Liabilities
$24.1B
CAGR 3-Years
15%
CAGR 5-Years
15%
CAGR 10-Years
17%
Cigna Corp
NYSE:CI
Accrued Liabilities
$8.9B
CAGR 3-Years
2%
CAGR 5-Years
2%
CAGR 10-Years
N/A
Laboratory Corporation of America Holdings
NYSE:LH
Accrued Liabilities
$820.6m
CAGR 3-Years
-22%
CAGR 5-Years
-5%
CAGR 10-Years
9%

See Also

What is Interpace Biosciences Inc's Accrued Liabilities?
Accrued Liabilities
8.9m USD

Based on the financial report for Mar 31, 2024, Interpace Biosciences Inc's Accrued Liabilities amounts to 8.9m USD.

What is Interpace Biosciences Inc's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 10Y
-7%

Over the last year, the Accrued Liabilities growth was 13%. The average annual Accrued Liabilities growth rates for Interpace Biosciences Inc have been -4% over the past three years , 7% over the past five years , and -7% over the past ten years .